RTA 402 Phase 3 Clinical Trial (A Randomized, Double-blind, Placebo-controlled Clinical Trial in Patients with Diabetic Kidney Disease)
Phase of Trial: Phase III
Latest Information Update: 08 Dec 2018
Price : $35 *
At a glance
- Drugs Bardoxolone methyl (Primary)
- Indications Diabetic neuropathies
- Focus Registrational; Therapeutic Use
- Sponsors Kyowa Hakko Kirin
- 11 May 2018 Status changed from planning to recruiting.
- 04 Apr 2018 New trial record
- 28 Mar 2018 According to a Kyowa Hakko Kirin media release, company plans to initiate this study in 2018 in Japan.